Podcast: Breaking Barriers in Pharma – The Pharmaoffer Journey to Digital Excellence

In this episode of The Digital Chemical Playbook, Florian Burnet, Digital Director at DKSH Performance Materials, sits down with Ammar Badwy, CEO of Pharmaoffer, for an insightful conversation on the digital transformation of the pharmaceutical ingredients industry.

 

Recorded amidst the energy of in-cosmetics Global 2025 in Amsterdam, the discussion explores how Pharmaoffer is reshaping the way pharmaceutical companies source and connect through digital platforms.

 

 

 

Here is our podcast summary for you:

Pharmaoffer was born out of a simple realisation: sourcing APIs (active pharmaceutical ingredients) was inefficient and fragmented. Drawing from his own experience in the pharmaceutical sector, Ammar saw the potential to digitize the process. The result? A platform that connects buyers and suppliers globally, enabling transparency, comparison, and trust—without losing the value of human connection.

What started as a bold idea in 2016 has evolved into a thriving platform with over 1.5 million users. Yet, as Ammar shares, it wasn’t an easy road. Convincing traditional pharma companies to embrace digital tools required persistence, education, and a hybrid model that respected existing procurement practices while offering a digital edge.

 

At its core, Pharmaoffer is not just a marketplace—it’s a matchmaking platform built on trust. Buyers are carefully verified to ensure quality connections, and suppliers are empowered to showcase their capabilities transparently. Unlike the early days of price-driven platforms, Pharmaoffer is built around relevance and fit. Users are encouraged to reach out to only three suppliers per request, maintaining the integrity of interactions and reducing noise.

The conversation delves into how Pharmaoffer balances digital innovation with the personal nature of B2B pharma transactions. While technology enables speed and visibility, relationships still play a pivotal role. The platform embraces this by allowing communication both within and outside its ecosystem, providing flexibility that larger pharma companies require.

 

One of Pharmaoffer’s greatest achievements is its user-centric design. As Florian highlights, the digital experience mirrors the ease and polish of leading B2C platforms—something rarely seen in B2B pharma sourcing. From intuitive searches to AI-powered matchmaking for CDMO requests, the platform reflects a deep understanding of user needs and market complexity.

AI is also leveraged to improve profiling, validate users, and match partners more intelligently—especially critical for CDMO (Contract Development and Manufacturing Organization) services, where finding the right partner is as much about compatibility as capability.

 

Ammar sees the future of Pharmaoffer in deeper data utilisation. With vast amounts of user interaction data, the team is investing in analytics and product development to deliver even more relevant experiences. There’s also a growing focus on biopharma, where innovation is accelerating and demand for specialized sourcing is on the rise.

Trust, traceability, and sustainability are also on the radar. While Pharmaoffer already offers transparency on certifications and company profiles, the long-term goal is to expand this into areas like sustainability claims and origin traceability—an increasingly important need in global pharma markets.

---

Listen to the full episode
Explore how Pharmaoffer is breaking traditional boundaries and pioneering digital excellence in API sourcing.

 

• Spotify, Amazon Music, and  Apple Podcast.
• Click here to watch the full episode on YouTube
• For more insights, visit pharmaoffer.com